ALEC Alector, Inc.: Net earnings per share for the last 12 months

Symbol and logo of brand Alector Therapeutics (ALEC)

The 12-month net income per share chart correlates with Alector, Inc. (ALEC) bioethical approach to drug development and the greening of laboratories, while 0.36 reflects the latest metric value. Pricing power potential is based on future patents, and partnerships with industry leaders temporarily offset market pressure in the neurodegeneration sector.

ALEC Alector, Inc. Net earnings per one share for the last twelve months (07/04/2022 - 11/12/2026)

Analytical breakdowns for Alector Inc. (ALEC)

- stock price and consensus target price:
Stock Price Alector Therapeutics|ALEC - Consensus Target
- company stock capitalization data:
Market Valuation Alector, Inc.|ALEC - Aggregate Business Value
- balance sheet net asset value indicators:
Net Assets per Single Share Alector|ALEC - Total Stockholders' Equity|Market Value to Book Value Ratio alector.com|ALEC - Aggregate Asset Value
- business debt structure and liquidity details:
Total Debt to Equity Ratio Alector, Inc.|ALEC - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Alector Therapeutics|ALEC - Company Total Debt Obligations|Debt to Book Capitalization Ratio Alector, Inc.|ALEC - Company Long-Term Indebtedness|Company Short-Term Debts Alector|Quick Liquidity Indicator alector.com
- earnings and multiples data:
ALEC - Net Financial Result|Projected Future Earnings Alector, Inc.|ALEC - P/E Multiple|Future Price to Earnings Alector Therapeutics|ALEC - Price/Earnings to Growth Ratio|EV/EBITDA Multiple Alector, Inc.|ALEC - Profit before interest, taxes and amortization|Net earnings per share (EPS TTM) Alector|ALEC - Net earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months alector.com|ALEC - Earnings per share growth this year|Earnings growth forecast for next year Alector, Inc.
Fundamental company analysis:ALEC - alector.com
Flagship merchandise of Alector Inc.

Investors are assessing the resilience of Alector, Inc. (ALEC), relying on low geopolitical volatility and the protection of Alzheimer's immunotherapy developments within US and EU jurisdictions. When analyzing the rolling annual earnings per share, it should be noted that this metric reflects net income distributed across the total share issuance, allowing for an objective assessment of the actual yield of each ownership stake and preventing overpayment for the asset.

Direct competitors

Biogen Inc. - Net earnings per share (EPS TTM)|neurocrine.com (NBIX) - Net earnings per share for the last 12 months|RGC (Regencell Bioscience Holdings Limited) - Net earnings per share for the last 12 months|AXSM: Earnings per share for the last four quarters|Earnings per share for the last twelve months ACADIA Pharmaceuticals Inc|Net earnings per one share for the last twelve months Xenon Corp XENE|Earnings per share for the last twelve months Viking Therapeutics (VKTX)|SUPN (supernus.com) - Earnings per share for the trailing year|Catalyst Pharmaceuticals, Inc. - Net earnings per share for the last 12 months|Earnings per share for the trailing year DNLI|Harmony Pharma - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Biohaven Corp BHVN|Amylyx Pharmaceuticals (AMLX) - Earnings per share for the last twelve months|Earnings per share for the last 12 months TRVI|PRAX (Praxis Precision Medicines, Inc.) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Anavex (AVXL)|Net earnings per share for the last 12 months CBLL (CeriBell Corp)|Net earnings per share for the last four quarters Prothena Biosciences|Net earnings per share (EPS TTM) ANNX (Annexon, Inc.)|Net earnings per share (EPS TTM) Omeros Corp OMER|NGNE - Earnings per share for the last twelve months|ACIU: Earnings per share for the last twelve months|VYGR: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Neumora Corp (NMRA)|SCLX (Scilex Holding Company) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months tevogen.com (TVGN)|Earnings per share for the last twelve months Alpha Cognition (ACOG)|Cognition Therapeutics Inc. - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) IKT (Inhibikase)|Cassava Pharma (SAVA) - Net earnings per one share for the last twelve months|ASRT: Net earnings per share for the last 12 months|COYA - Net earnings per share (EPS TTM)|vistagen.com (VTGN) - Earnings per share for the last twelve months|Ovid Therapeutics - Earnings per share for the trailing year|Earnings per share for the last twelve months Acumen Pharma|Net earnings per one share for the last twelve months CervoMed Corporation CRVO|Net earnings per share (EPS TTM) ATHE|Net earnings per share (EPS TTM) clene.com (CLNN)|Earnings per share for the last twelve months PepGen PEPG|Jupiter Neurosciences, Inc. - Earnings per share for the last twelve months|Relmada - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Annovis Bio Corporation|GRCE: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months fireflyneuro.com|Net earnings per share for the last 12 months KLTO|NRSN (NeuroSense Therapeutics, Ltd.) - Earnings per share for the last four quarters|Earnings per share for the last twelve months Reviva Pharmaceuticals Holdings (RVPH)|MTVA - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months NeurAxis, Inc. NRXS|Earnings per share for the trailing year HSDT|PASG: Net earnings per share for the last 12 months|Earnings per share for the trailing year NEUP (Neuphoria Therapeutics Inc.)|NERV: Net earnings per share (EPS TTM)|ATHA - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Addex Therapeutics|Earnings per share for the last 12 months ALZN (Alzamend)|Net earnings per share (EPS TTM) CYCN|Net earnings per share for the last 12 months protagenic.com PTIX|Pasithea Therapeutics Corp. - Net earnings per share for the last 12 months|Net earnings per share for the last four quarters Cortigent Inc (CRGT)|Avenue Therapeutics - Net earnings per share (EPS TTM)|BCLI - Net earnings per share (EPS TTM)|Cara Therapeutics (CARA) - Earnings per share for the last twelve months|CHRO (Chromocell Therapeutics Corp) - Earnings per share for the last twelve months|ELYM (Eliem Therapeutics, Inc.) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Intra-Cellular ITCI|Net earnings per share (EPS TTM) LBPH|Net earnings per share for the last 12 months marinuspharma.com MRNS|Earnings per share for the last twelve months NKGen Biotech NKGN|NRBO: Earnings per share for the last 12 months|Sage Therapeutics, Inc - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Synaptogenix, Inc|TRVN (Trevena, Inc.) - Net earnings per share for the last 12 months|Vigil Neuroscience, Inc. (VIGL) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Anew Medical|CERE: Earnings per share for the trailing year